vs

Side-by-side financial comparison of Midland States Bancorp, Inc. (MSBI) and SOLENO THERAPEUTICS INC (SLNO). Click either name above to swap in a different company.

Midland States Bancorp, Inc. is the larger business by last-quarter revenue ($79.5M vs $66.0M, roughly 1.2× SOLENO THERAPEUTICS INC). SOLENO THERAPEUTICS INC runs the higher net margin — 39.4% vs 23.2%, a 16.2% gap on every dollar of revenue.

Rainier Bancorporation was the Seattle-based parent corporation of Rainier National Bank, a Washington state bank with branches throughout the state. Rainier traced its roots back to the National Bank of Commerce, which was founded by Richard Holyoke in 1889. The name Rainier National Bank was adopted in 1974. Rainier Bancorp expanded into Alaska with the purchase of Anchorage's People's Bank & Trust in 1983 and into Oregon with the purchase of Gresham's Mount Hood Security Bank in 1986, expa...

SOLENO THERAPEUTICS INC is a clinical-stage biopharmaceutical company specializing in developing novel therapies for rare endocrine, metabolic, and neurodevelopmental disorders. Its lead product candidate targets Prader-Willi syndrome, a rare genetic condition, with key patient markets across North America and the European Union.

MSBI vs SLNO — Head-to-Head

Bigger by revenue
MSBI
MSBI
1.2× larger
MSBI
$79.5M
$66.0M
SLNO
Higher net margin
SLNO
SLNO
16.2% more per $
SLNO
39.4%
23.2%
MSBI

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
MSBI
MSBI
SLNO
SLNO
Revenue
$79.5M
$66.0M
Net Profit
$18.5M
$26.0M
Gross Margin
98.3%
Operating Margin
33.5%
Net Margin
23.2%
39.4%
Revenue YoY
Net Profit YoY
739.3%
134.0%
EPS (diluted)
$0.74
$0.47

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MSBI
MSBI
SLNO
SLNO
Q1 26
$79.5M
Q4 25
$85.6M
Q3 25
$81.1M
$66.0M
Q2 25
$82.2M
$32.7M
Q1 25
$76.1M
Q4 24
$93.9M
Q3 24
$92.7M
Q2 24
$90.9M
Net Profit
MSBI
MSBI
SLNO
SLNO
Q1 26
$18.5M
Q4 25
$-2.9M
Q3 25
$7.6M
$26.0M
Q2 25
$12.0M
$-4.7M
Q1 25
$-141.0M
Q4 24
$-30.8M
Q3 24
$20.4M
Q2 24
$25.7M
Gross Margin
MSBI
MSBI
SLNO
SLNO
Q1 26
Q4 25
Q3 25
98.3%
Q2 25
97.9%
Q1 25
Q4 24
Q3 24
Q2 24
Operating Margin
MSBI
MSBI
SLNO
SLNO
Q1 26
Q4 25
-5.5%
Q3 25
13.9%
33.5%
Q2 25
18.1%
-20.0%
Q1 25
-181.2%
Q4 24
-66.5%
Q3 24
26.9%
Q2 24
35.0%
Net Margin
MSBI
MSBI
SLNO
SLNO
Q1 26
23.2%
Q4 25
-4.9%
Q3 25
9.3%
39.4%
Q2 25
14.6%
-14.4%
Q1 25
-185.4%
Q4 24
-52.5%
Q3 24
22.1%
Q2 24
28.3%
EPS (diluted)
MSBI
MSBI
SLNO
SLNO
Q1 26
$0.74
Q4 25
$-0.22
Q3 25
$0.24
$0.47
Q2 25
$0.44
$-0.09
Q1 25
$-6.58
Q4 24
$-1.49
Q3 24
$0.83
Q2 24
$1.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MSBI
MSBI
SLNO
SLNO
Cash + ST InvestmentsLiquidity on hand
$89.4M
$498.9M
Total DebtLower is stronger
$33.2M
Stockholders' EquityBook value
$569.5M
$494.8M
Total Assets
$6.5B
$599.9M
Debt / EquityLower = less leverage
0.06×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MSBI
MSBI
SLNO
SLNO
Q1 26
$89.4M
Q4 25
$127.8M
Q3 25
$166.1M
$498.9M
Q2 25
$176.6M
$286.8M
Q1 25
$102.0M
Q4 24
$114.8M
Q3 24
$121.9M
Q2 24
$124.6M
Total Debt
MSBI
MSBI
SLNO
SLNO
Q1 26
$33.2M
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
MSBI
MSBI
SLNO
SLNO
Q1 26
$569.5M
Q4 25
$565.5M
Q3 25
$584.0M
$494.8M
Q2 25
$573.7M
$240.1M
Q1 25
$571.4M
Q4 24
$710.8M
Q3 24
$771.2M
Q2 24
$736.8M
Total Assets
MSBI
MSBI
SLNO
SLNO
Q1 26
$6.5B
Q4 25
$6.5B
Q3 25
$6.9B
$599.9M
Q2 25
$7.1B
$332.3M
Q1 25
$7.3B
Q4 24
$7.5B
Q3 24
$7.7B
Q2 24
$7.7B
Debt / Equity
MSBI
MSBI
SLNO
SLNO
Q1 26
0.06×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MSBI
MSBI
SLNO
SLNO
Operating Cash FlowLast quarter
$43.5M
Free Cash FlowOCF − Capex
$43.5M
FCF MarginFCF / Revenue
65.8%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
1.67×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MSBI
MSBI
SLNO
SLNO
Q1 26
Q4 25
$125.7M
Q3 25
$80.0M
$43.5M
Q2 25
$28.1M
$-12.6M
Q1 25
$24.7M
Q4 24
$176.5M
Q3 24
$46.5M
Q2 24
$31.4M
Free Cash Flow
MSBI
MSBI
SLNO
SLNO
Q1 26
Q4 25
$120.3M
Q3 25
$78.6M
$43.5M
Q2 25
$26.7M
$-12.6M
Q1 25
$22.9M
Q4 24
$169.6M
Q3 24
$44.4M
Q2 24
$29.9M
FCF Margin
MSBI
MSBI
SLNO
SLNO
Q1 26
Q4 25
140.6%
Q3 25
96.9%
65.8%
Q2 25
32.4%
-38.6%
Q1 25
30.1%
Q4 24
180.6%
Q3 24
47.9%
Q2 24
32.9%
Capex Intensity
MSBI
MSBI
SLNO
SLNO
Q1 26
Q4 25
6.2%
Q3 25
1.7%
0.0%
Q2 25
1.7%
0.0%
Q1 25
2.4%
Q4 24
7.3%
Q3 24
2.3%
Q2 24
1.7%
Cash Conversion
MSBI
MSBI
SLNO
SLNO
Q1 26
Q4 25
Q3 25
10.58×
1.67×
Q2 25
2.33×
Q1 25
Q4 24
Q3 24
2.28×
Q2 24
1.22×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MSBI
MSBI

Net Interest Income$57.4M72%
Noninterest Income$22.1M28%

SLNO
SLNO

Segment breakdown not available.

Related Comparisons